GEP201606594B - Pharmaceutical composition of sedative and spasmolytic action in soft gelatin capsules (variations) - Google Patents

Pharmaceutical composition of sedative and spasmolytic action in soft gelatin capsules (variations)

Info

Publication number
GEP201606594B
GEP201606594B GEAP201413565A GEAP2014013565A GEP201606594B GE P201606594 B GEP201606594 B GE P201606594B GE AP201413565 A GEAP201413565 A GE AP201413565A GE AP2014013565 A GEAP2014013565 A GE AP2014013565A GE P201606594 B GEP201606594 B GE P201606594B
Authority
GE
Georgia
Prior art keywords
sedative
pharmaceutical composition
gelatin capsules
soft gelatin
variations
Prior art date
Application number
GEAP201413565A
Inventor
Lidia Filipovna Chumashenko
Original Assignee
Bioscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioscience Ltd filed Critical Bioscience Ltd
Publication of GEP201606594B publication Critical patent/GEP201606594B/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

An invention relates to pharmaceutical composition of therapeutic agent of sedative and spasmolytic action in soft gelatin capsules, containing α-bromisovaleric acid ethyl ether, additional componentry and menthol solution in isovaleric acid methyl ether.
GEAP201413565A 2013-11-20 2014-09-01 Pharmaceutical composition of sedative and spasmolytic action in soft gelatin capsules (variations) GEP201606594B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201313521A UA107631C2 (en) 2013-11-20 2013-11-20 PHARMACEUTICAL COMPOSITION OF MEDICINAL PRODUCT OF SEDATIVE AND SPASMOLITIC ACTION IN THE FORM OF SOFT GELATIN Capsules (OPTIONS)

Publications (1)

Publication Number Publication Date
GEP201606594B true GEP201606594B (en) 2017-01-10

Family

ID=52989098

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP201413565A GEP201606594B (en) 2013-11-20 2014-09-01 Pharmaceutical composition of sedative and spasmolytic action in soft gelatin capsules (variations)

Country Status (3)

Country Link
GE (1) GEP201606594B (en)
RU (1) RU2580290C2 (en)
UA (1) UA107631C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2682888C2 (en) * 2016-08-01 2019-03-22 Валентина Васильевна Марченкова Complex of biologically active substances for express relaxation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA75723C2 (en) * 2004-04-30 2006-05-15 Viacheslav Vasyliov Lavrinenko Electrical window raiser
UA77909C2 (en) * 2005-11-03 2007-01-15 Filia Ivanivna Zhebrovska Sedative and hypnotic drug
UA95549C2 (en) * 2010-03-01 2011-08-10 Филя Ивановна Жебровская encapsulated drug of sedative and antispasmodic action and method of manufacture thereof
UA75204U (en) * 2012-05-04 2012-11-26 Публічне Акціонерне Товариство "Київський Вітамінний Завод" antispasmodic and sedative drug in the form of soft gelatin capsules

Also Published As

Publication number Publication date
RU2580290C2 (en) 2016-04-10
RU2013156851A (en) 2015-06-27
UA107631C2 (en) 2015-01-26

Similar Documents

Publication Publication Date Title
MX2019006878A (en) Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drug.
MX2021000550A (en) Tofacitinib oral sustained release dosage forms.
EA201500742A1 (en) PHARMACEUTICAL COMPOSITIONS PROTECTED FROM NON-GOAL USE
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
PL3043773T3 (en) Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine for nasal administration
TN2016000007A1 (en) Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
MX2016005395A (en) Stable formulation of insulin glulisine.
PH12016500978A1 (en) Piperazine derivatives having multimodal activity against pain
BR112016006171A2 (en) Foam formulations and device for your delivery
MX2015005762A (en) Co-micronisation product comprising ulipristal acetate.
HK1222337A1 (en) Topical composition and carrier for administration of pharmaceutical or cosmetic active ingredients
MX2015010486A (en) Chewable composition for oral administration and process for preparing thereof.
GEP201606594B (en) Pharmaceutical composition of sedative and spasmolytic action in soft gelatin capsules (variations)
MX2018010065A (en) Oral dosage form comprising rifaximin in form beta.
UA75204U (en) antispasmodic and sedative drug in the form of soft gelatin capsules
EP3064201A4 (en) Pharmaceutical composition for preventing and treating central nervous system diseases containing fluoxetine and vitamin c as active ingredients
UA90602U (en) Combined pharmaceutical composition
GR1008380B (en) Pharmaceutical composition comprising an antiviral agent and method for the preparation thereof
EA201992463A1 (en) DRUG DELIVERY SYSTEM
CR20120465A (en) IMPROVED FORMULATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF DEFICIENT PERMEABILITY
MX2015013279A (en) Tofacitinib oral sustained release dosage forms.
MX366763B (en) PHARMACEUTICAL COMPOSITIONS OF MONTELUKAST and LEVOCETIRIZINE.
UA107884C2 (en) Combined anti-tuberculosis drug